Form 4: Director Hedley Acquires Shares of Eli Lilly & Co (LLY) Through Directors' Deferral Plan

Mary Lynne Hedley, a director of Eli Lilly & Co, acquired 12.024 shares of common stock at $824.76 per share through the Lilly Directors' Deferral Plan.

Summary

• On March 17, 2025, Mary Lynne Hedley, a director of Eli Lilly & Co, acquired 12.024 shares of common stock.
• The shares were acquired at a price of $824.76 per share.
• The acquisition was made through the Lilly Directors' Deferral Plan, where shares are deferred in lieu of cash compensation.
• Following the transaction, Hedley directly owns 1,918.904 shares of Eli Lilly common stock.
• Hedley also indirectly owns 98 shares through a trust, but disclaims beneficial ownership except to the extent of her pecuniary interest.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares suggests confidence in the company, but it's part of a standard compensation plan.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The acquired shares will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

Director share acquisitions are common and closely monitored as they provide insights into management's perspective on the company's valuation and future performance. This transaction is part of the standard compensation and deferral plans offered to directors.

Comparison to Industry Standards

• Director compensation packages often include stock options, restricted stock units, and deferred stock plans.
• The Lilly Directors' Deferral Plan is similar to those offered by other large pharmaceutical companies such as Pfizer (PFE) and Johnson & Johnson (JNJ), allowing directors to defer cash compensation into company stock.
• The specific terms and amounts may vary, but the general structure is consistent with industry practices.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals director confidence.
• There is no significant impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Eli Lilly, LLY, Director, Share Acquisition, Form 4, Hedley, Directors' Deferral Plan, Beneficial Ownership